Mechanisms of p-Methoxycinnamic Acid-induced Increase in Insulin Secretion

Abstract

p-Methoxycinnamic acid (p-MCA) is a cinnamic acid derivative that shows various pharmacologic actions such as hepatoprotective and antihyperglycemic activities. The present study was to elucidate the mechanisms by which p-MCA increases [Ca²⁺]_i and insulin secretion in INS-1 cells. p-MCA (100 μM) increased [Ca²⁺]_i in INS-1 cells. The p-MCA-induced insulin secretion and rise in [Ca²⁺]_i were markedly inhibited in the absence of extracellular Ca²⁺ or in the presence of an L-type Ca²⁺ channel blocker nimodipine. These results suggested that p-MCA increased Ca²⁺ influx via the L-type Ca²⁺ channels. Diazoxide, an ATP-sensitive K⁺ channel opener, did not alter p-MCA-induced insulin secretion, nor [Ca²⁺]_i response. In addition, p-MCA enhanced glucose-, glibenclamide-induced insulin secretion whereas it also potentiated the increase in insulin secretion induced by arginine, and Bay K 8644, an L-type Ca²⁺ channel agonist. Taken together, our results suggest that p-MCA stimulated insulin secretion from pancreatic β-cells by increasing Ca²⁺ influx via the L-type Ca²⁺ channels, but not through the closure of ATP-sensitive K⁺ channels.

Key words

p-methoxycinnamic acid - diabetes - insulin secretion - INS-1 cells - Ca²⁺ influx

• References

• 1 Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005; 115: 2047-2058
• 2 Renström E, Barg S, Thévenod F, Rorsman P. Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action. Diabetes 2002; 51 (Suppl. 01) S33-S36
• 3 Rajan AS, Aguilar-Bryan L, Nelson DA, Yaney GC, Hsu WH, Kunze DL, Boyd AE. Ion channels and insulin secretion. Diabetes Care 1990; 13: 340-363
• 4 Jackson JE, Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents. (part 1) Drugs 1981; 22: 211-245
• 5 Ferner RE. Neil HAW. Sulphonylureas and hypoglycaemia. Br Med J 1988; 296: 949-950
• 6 Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989; 321: 1231-1245
• 7 Jennings A, Wilson R, Ward J. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 1989; 12: 203-208
• 8 Perez-Alvarez V, Bobadilla RA, Muriel P. Structure-hepatoprotective activity relationship of 3,4-dihydroxycinnamic acid (caffeic acid) derivatives. J Appl Toxicol 2001; 21: 527-531
• 9 Wiesner J, Mitsch A, Wissner P, Jomaa H, Schlitzer M. Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives. Bioorg Med Chem Lett 2001; 11: 423-424
• 10 Natella F, Nardini M, Di Felice M, Scaccini C. Benzoic and cinnamic acid derivatives as antioxidants: structure-activity relation. J Agric Food Chem 1999; 47: 1453-1459
• 11 Liu IM, Chi TC, Hsu FL, Chen CF, Cheng JT. Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats. Planta Med 1999; 65: 712-714
• 12 Nomura E, Kashiwada A, Hosoda A, Nakamura K, Morishita H, Tsuno T, Taniguchi H. Synthesis of amide compounds of ferulic acid, and their stimulatory effects on insulin secretion in vitro. Bioorg Med Chem 2003; 11: 3807-3813
• 13 Adisakwattana S, Moonsan P, Yibchok-Anun S. Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem 2008; 56: 7838-7844
• 14 Adisakwattana S, Chantarasinlapin P, Thammarat H, Yibchok-Anun S. A series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J Enzyme Inhib Med Chem 2009; 24: 1194-2000
• 15 Kim SR, Kang SY, Lee KY, Kim SH, Markelonis GJ, Oh TH, Kim YC. Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana . Brain Res Cogn Brain Res 2003; 17: 454-461
• 16 Bylka W. E- and Z-p-methoxycinnamic acid from Aquilegia vulgaris . Acta Pol Pharm 2004; 61: 307-308
• 17 Lee EJ, Kim SR, Kim J, Kim YC. Hepatoprotective phenylpropanoids from Scrophularia buergeriana roots against CCl₄-induced toxicity: action mechanism and structure-activity relationship. Planta Med 2002; 68: 407-411
• 18 Kim SR, Sung SH, Jang YP, Markelonis GJ, Oh TH, Kim YC. E-p-methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate. Br J Pharmacol 2002; 135: 1281-1291
• 19 Adisakwattana S, Sookkongwaree K, Roengsumran S, Petsom A, Ngamrojnavanich N, Chavasiri W, Deesamer S, Yibchok-anun S. Structure-activity relationships of trans-cinnamic acid derivatives on alpha-glucosidase inhibition. Bioorg Med Chem Lett 2004; 14: 2893-2896
• 20 Yibchok-Anun S, Adisakwattana S, Moonsan P, Hsu WH. Insulin secretagogue activity of p-methoxycinnamic acid in rats, perfused rat pancreas and pancreatic β-cell line. Basic Clin Pharmacol Toxicol 2008; 102: 476-482
• 21 Adisakwattana S, Roengsamran S, Hsu WH, Yibchok-Anun S. Mechanisms of antihyperglycemic effect of p-methoxycinnamic acid in normal and streptozotocin-induced diabetic rats. Life Sci 2005; 78: 406-412
• 22 Hsu WH, Xiang HD, Rajan AS, Kunze DL, Boyd 3rd AE. Somatostatin inhibits insulin secretion by a G-protein-mediated decrease in Ca²⁺ entry through voltage-dependent Ca²⁺ channels in the beta cell. J Biol Chem 1991; 266: 837-843
• 23 Cheng H, Grodnitzky JA, Yibchok-anun S, Ding J, Hsu WH. Somatostatin increases phospholipase D activity and phosphatidylinositol 4.5-bisphosphate synthesis in clonal β-cells HIT-T15. Mol Pharmacol 2005; 67: 2162-2172
• 24 Yibchok-Anun S, Jittaprasatsin W, Somtir D, Bunlunara W, Adisakwattana S. Insulin secreting and α-glucosidase inhibitory activity of Coscinium fenestratum and postprandial hyperglycemia in normal and diabetic rats. J Med Plants Res 2009; 3: 646-651
• 25 Ämmälä C, Moorhouse A, Ashcroft FM. The sulphonylurea receptor confers diazoxide sensitivity on the inwardly rectifying K⁺ channel Kir6.1 expressed in human embryonic kidney cells. J Physiol 1996; 494: 709-714
• 26 Park KH, Song SC, Akaike T. Determination of the specific interaction between sulfonylurea-incorporated polymer and rat islets. J Biochem (Tokyo) 2002; 131: 359-364
• 27 Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium 2005; 38: 233-252
• 28 Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, Earley TJ, Patapoutian A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004; 41: 849-857
• 29 Liu Z, Jeppesen PB, Gregersen S, Chen X, Hermansen K. Dose- and glucose-dependent effects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E beta-cells. Rev Diabet Stud 2008; 5: 232-244
• 31 Thams P, Capito K. l-Arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide. Eur J Endocrinol 1999; 140: 87-93
• 30 Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti KG. Long-Term oral l-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 2001; 24: 875-880
• 32 Striessnig J, Murphy BJ, Catterall WA. Dihydropyridine receptor of L-type Ca²⁺ channels: identification of binding domains for [³H](+)-PN200-110 and [³H]azidopine within the alpha 1 subunit. Proc Natl Acad Sci USA 1991; 88: 10769-10773
• 33 Skasa M, Jungling E, Picht E, Schondube F, Luckhoff A. L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. Basic Res Cardiol 2001; 96: 151-159
• 34 Larsson-Nyren G, Sehlin J. Comparison of the effects of perchlorate and Bay K 8644 on the dynamics of cytoplasmic Ca²⁺ concentration and insulin secretion in mouse beta-cells. Biochem J 1996; 314: 167-173
• 35 Hofmann F, Lacinova L, Klugbauer N. Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol 1999; 139: 33-87